American Heart Association (AHA) Scientific Sessions 2024
Johns Hopkins specialists will participate in AHA Scientific Sessions 2024 from November 16–18. Choose a date below to see the schedule of presentations and additional details. All times listed are in Central Standard Time (CST).
View Schedule by Date
November 16, 2024
9:45 AM - 11 AM
Beneath the Surface: Subclinical Cardiovascular Disease and Prevention
Erin Michos, M.D.
Director of Women's Cardiovascular Health Research
Associate Director of Preventative Cardiology
10:41 AM - 10:48 AM
Wearables for Sub-Clinical Atrial Fibrillation: Capitalizing on Technology
Nino Isakadze, M.D., MHSAssistant Professor of Medicine
11:10 AM - 12:35 PM
CVD Before, During and After Pregnancy— Emerging Science
Anum Minhas, M.D., MHS
Assistant Professor of Medicine, Cardiology
1:45 PM - 1:55 PM
The Evolution from Statins to Monoclonal Antibodies and Antisense Technology for Lipid Lowering
Erin Michos, M.D.
Director of Women's Cardiovascular Health Research
Associate Director of Preventative Cardiology
2:50 PM - 4:15 PM
The Crystal Ball of CVD Risk Assessment
Erin Michos, M.D.
Director of Women's Cardiovascular Health Research
Associate Director of Preventative Cardiology
3:15 PM - 4:30 PM
Personalizing CV Risk: The Science of CKM Risk Enhancers
Anum Minhas, M.D., MHS
Assistant Professor of Medicine, Cardiology
3:55 PM - 4:30 PM
AI Everywhere
Nino Isakadze, M.D., MHS
Assistant Professor of Medicine
November 17, 2024
11:10 AM - 12:35 PM
The Return of the Antiarrhythmic Drug Therapy: A New Age with New Therapeutics
Nino Isakadze, M.D., MHS
Assistant Professor of Medicine
3:15 PM - 4:15 PM
Maternal Plasma Proteome: Associations with Blood Pressure During Pregnancy and Postpartum
Anum Minhas, M.D., MHS
Assistant Professor of Medicine, Cardiology
3:30 PM - 3:42 PM
The AHA CMK Health Initiative: The Future of Holistic Care
Chiadi Ndumele, M.D., Ph.D., MHS
Associate Professor of Medicine
4:40 PM - 4:42 PM
Panelist: Impact on Women
Erin Michos, M.D.
Director of Women's Cardiovascular Health Research
Associate Director of Preventative Cardiology
Patient Interview/GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics
Chiadi Ndumele, M.D., Ph.D., MHS
Associate Professor of Medicine
November 18, 2024
2:00 PM - 2:05 PM
The Association of PREVENT-HF Risk Estimates with Subclinical (Stage B) HF and Clinical Implications for HF Risk: The Atherosclerosis Risk in Communities (ARIC) Study)
Jelani Grant, MBBS
Cardiology
1:30 PM - 2:45 PM
Featured Science: Incretin Modulation: Is a New Standard of Care Emerging
Chiadi Ndumele, M.D., Ph.D., MHS
Associate Professor of Medicine
1:30 PM - 2:45 PM
New Targets and New Treatments: Advances in Lipid Therapeutics
Erin Michos, M.D.
Director of Women's Cardiovascular Health Research
Associate Director of Preventative Cardiology
2:21 PM - 3:31 PM
Incretin Analogues for Addressing Multisystem Morbidity
Chiadi Ndumele, M.D., Ph.D., MHS
Associate Professor of Medicine